126
Views
5
CrossRef citations to date
0
Altmetric
Articles

Cloning, large-scale production and characterization of fusion protein (P-TUFT-ALT-2) of Brugian abundant larval transcript-2 with tuftsin in Pichia pastoris

, , , &
Pages 823-833 | Received 30 Apr 2018, Accepted 04 Aug 2018, Published online: 10 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vivek P Chavda, Anjali Pandya, Sreeranjini Pulakkat, Moinuddin Soniwala & Vandana Patravale. (2021) Lymphatic filariasis vaccine development: neglected for how long?. Expert Review of Vaccines 20:11, pages 1471-1482.
Read now

Articles from other publishers (4)

Premnath Madanagopal, Sathya Muthusamy, Satya Narayan Pradhan & Prabhu Rajaiah Prince. (2023) Construction and validation of a multi-epitope in silico vaccine model for lymphatic filariasis by targeting Brugia malayi: a reverse vaccinology approach. Bulletin of the National Research Centre 47:1.
Crossref
Alexander Kwarteng, Ebenezer Asiedu, Kelvin Kwaku Koranteng & Samuel Opoku Asiedu. (2021) Highlighting the Relevance of CD8+ T Cells in Filarial Infections. Frontiers in Immunology 12.
Crossref
Ramaswamy Kalyanasundaram, Vishal Khatri & Nikhil Chauhan. (2020) Advances in Vaccine Development for Human Lymphatic Filariasis. Trends in Parasitology 36:2, pages 195-205.
Crossref
Rajkumar Paul, Meganathan Ilamaran, Vishal Khatri, Nitin Amdare, Maryada Venkata Rami Reddy & Perumal Kaliraj. (2019) Immunological evaluation of fusion protein of Brugia malayi abundant larval protein transcript-2 (BmALT-2) and Tuftsin in experimental mice model. Parasite Epidemiology and Control 4, pages e00092.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.